Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: A randomized, double-blinded cross-over trial

FEMS Microbiology Ecology

Volumn 90, Issue 1, 2014, Pages 225-236

  van Zanten, Gabriella C ^a   Krych, Lukasz ^a   Röytiö, Henna ^b,c   Forssten, Sofia ^b   Lahtinen, Sampo J ^b   Al Soud, Waleed Abu ^a   Sørensen, Søren ^a   Svensson, Birte ^a   Jespersen, Lene ^a   Jakobsen, Mogens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DUPONT COMPANY   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Bifidobacterium; Lactobacillus; Branched chain fatty acids; Human trial; Microbial community sequencing; Synbiotics

Indexed keywords

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS NCFM;

CELLOBIOSE; FATTY ACID; SYNBIOTIC AGENT; VOLATILE FATTY ACID;

ADULT; BIFIDOBACTERIUM; BIODIVERSITY; BIOSYNTHESIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GENETICS; HUMAN; INTESTINE; ISOLATION AND PURIFICATION; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; MALE; MICROBIOLOGY; MICROFLORA; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; BIFIDOBACTERIUM; BIODIVERSITY; CELLOBIOSE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FATTY ACIDS; FATTY ACIDS, VOLATILE; FEMALE; HUMANS; INTESTINES; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; MALE; MICROBIOTA; SYNBIOTICS; YOUNG ADULT;

EID: 84907895037     PISSN: 01686496     EISSN: 15746941     Source Type: Journal    
DOI: 10.1111/1574-6941.12397     Document Type: Article

References (63)

1. Altermann E, Russel MW, Azcarate-Peril AM et al. (2005) Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. P Natl Acad Sci USA 102: 3906-3912.
2. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg RMG, Møller K, Svendsen KD, Jakobsen M & Pedersen BK (2010) Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104: 1831-1838.
3. Bartosch S, Woodmansey EJ, Paterson JCM, McMurdo MET & Macfarlane GT (2005) Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 40: 28-37.
4. Björklund M, Ouwehand AC, Forssten SD, Nikkilä J, Tiihonen K, Rautonen N & Lahtinen SJ (2011) Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol. Age 34: 987-999.
5. Brooks JB, Nunez-Montiel OL, Basta MT & Hierholzer JC (1984) Studies of stools from pseudomembranous colitis, rotaviral, and other diarrheal syndromes by frequency-pulsed electron capture gas-liquid chromatography. J Clin Microbiol 20: 549-560.
6. Caporaso JG, Kuczynski J, Stombaugh J et al. (2010) qiime allows analysis of high-throughput community sequencing data. Nat Methods 7: 335-336.
7. Casiraghi MC, Canzi E, Zanchi R, Donati E & Villa L (2007) Effects of a synbiotic milk product on human intestinal ecosystem. J Appl Microbiol 103: 499-506.
8. Damager I, Denyer K, Motawia MS, Møller BL & Blennow A (2001) The action of starch synthase II on 6″′-α-maltotriosyl-maltohexaose comprising the branch point of amylopectin. Eur J Biochem 268: 4878-4884.
9. Davis LMG, Martínez I, Walter J, Goin C & Hutkins RW (2011) Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 6: e25200.
10. De Preter V, Ghebretinsae AH, Abrahantes JC, Windey K, Rutgeerts P & Verbeke K (2011) Impact of the synbiotic combination of Lactobacillus casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in healthy subjects. Mol Nutr Food Res 55: 714-722.
11. Gøbel R, Larsen N, Mølgaard C, Jakobsen M & Michaelsen KF (2010) Probiotics to young children with atopic dermatitis: a randomized placebo-controlled trial. Int J Probiotics Prebiotics 5: 53-60.
12. Goossen DS, Jonker DS, Russel M, Stobberingh E, van den Bogaard AEJM & Stockbrügger R (2003) The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers : a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 18: 495-505.
13. Gråsten S, Liukkonen K-H, Chrevatidis A, El-Nezami H, Poutanen K & Mykkänen H (2003) Effects of wheat pentosan and inulin on the metabolic activity of fecal microbiota and on bowel function in healthy humans. Nutr Res 23: 1503-1514.
14. Heilig HGHJ, Zoetendal EG, Vaughan EE, Marteau P, Akkermans ADL & de Vos WM (2002) Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 68: 114-123.
15. Holben WE, Williams P, Gilbert MA, Saarinen M, Särkilahti LK & Apajalahti JHA (2002) Phylogenetic analysis of intestinal microflora indicates a novel Mycoplasma phylotype in farmed and wild salmon. Microb Ecol 44: 175-185.
16. Hooda S, Boler BMV, Serao MCR, Brulc JM, Staeger MA, Boileau TW, Dowd SE, Fahey GC Jr & Swanson KS (2012) 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. J Nutr, 142: 1259-1265.
17. Huda-Faujan N, Abdulamir AS, Fatimah AB, Anas OM, Shuhaimi M, Yazid AM & Loong YY (2010) The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4: 53-58.
18. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P & Vermeire S (2011) Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60: 631-637.
19. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J & Palva A (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133: 24-33.
20. Kekkonen RA, Holma R, Hatakka K, Suomalainen T, Poussa T, Adlercreutz H & Korpela R (2011) A probiotic mixture including galactooligosaccharides decreases fecal β-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention. J Nutr 141: 870-876.
21. Kim S-W, Suda W, Kim S, Oshima K, Fukuda S, Ohno H, Morita H & Hattori M (2013) Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 20: 241-253.
22. Koning CJM, Jonkers DMAE, Stobberingh EE, Mulder L, Rombouts FM & Stockbrügger RW (2008) The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroentrol 103: 178-189.
23. Lahti L, Salonen A, Kekkonen RA, Salojärvi J, Jalanka-Tuovinen J, Palva A, Orešič M & de Vos WM (2013) Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. PeerJ 1: e32.
24. Larsen N, Vogensen FK, van den Berg FWJ et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5: e9085.
25. Larsen N, Vogensen FK, Gøbel R, Michaelsen KF, Abu Al-Soud W, Sørensen SJ, Hansen LH & Jakobsen M (2011) Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. FEMS Microbiol Ecol 75: 482-496.
26. Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK & Narbad A (2011) Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res 10: 4208-4218.
27. Ley RE, Turnbaugh PJ, Klein S & Gordon JI (2006) Human gut microbes associated with obesity. Nature 444: 1022-1023.
28. Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L & Palva A (2009) Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 15: 5936.
29. Macfarlane GT & Macfarlane S (2012) Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 95: 50-60.
30. Macfarlane S, Cleary S, Bahrami B, Reynolds N & Macfarlane GT (2013) Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther 38: 804-816.
31. Martínez I, Kim J, Duffy PR, Schlegel VL & Walter J (2010) Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 5: e15046.
32. Masoud W, Takamiya M, Vogensen FK, Lillevang S, Al-Soud WA, Sørensen SJ & Jakobsen M (2011) Characterization of bacterial populations in Danish raw milk cheeses made with different starter cultures by denaturating gradient gel electrophoresis and pyrosequencing. Int Dairy J 21: 142-148.
33. McNulty NP, Yatsunenko T, Hsiao A et al. (2011) The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3: 106ra106.
34. Munukka E, Wiklund P, Pekkala S et al. (2012) Women with and without metabolic disorder differ in their gut microbiota composition. Obesity 20: 1082-1087.
35. Nakamura S, Oku T & Ichinose M (2004) Bioavailability of cellobiose by tolerance test and breath hydrogen excretion in humans. Nutrition 20: 979-983.
36. Ndagijimana M, Laghi L, Vitali B, Placucci G, Brigidi P & Guerzoni ME (2009) Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by (1)H Nuclear Magnetic Resonance spectroscopy. Int J Food Microbiol 134: 147-153.
37. Nilsson U, Johansson M, Nilsson A, Björck I & Nyman M (2008) Dietary supplementation with beta-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects. Eur J Clin Nutr 62: 978-984.
38. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H & Rautonen N (2009) Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 101: 367-375.
39. Qin J, Li Y, Cai Z et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60.
40. Quigley EMM (2011) Gut microbiota and the role of probiotics in therapy. Curr Opin Pharmacol 11: 593-603.
41. Roberfroid M, Gibson GR, Hoyles L et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104(suppl): S1-S63.
42. Roessler A, Forssten SD, Glei M, Ouwehand AC & Jahreis G (2011) The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study. Clin Nutr 31: 22-29.
43. Sanders ME (2011) Impact of probiotics on colonizing microbiota of the gut. J Clin Gastroenterol 45(Suppl): S115-S119.
44. Sanders ME & Klaenhammer TR (2001) The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 84: 319-331.
45. Sanz ML, Gibson GR & Rastall RA (2005) Influence of disaccharide structure on prebiotic selectivity in vitro. J Agric Food Chem 53: 5192-5199.
46. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C & Hardt PD (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
47. Sekirov I, Russell SL, Antunes LCM & Finlay BB (2010) Gut microbiota in health and disease. Phys Rev 90: 859-904.
48. Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28: 405-440.
49. Shioiri T, Yahagi K, Nakamaya S et al. (2006) The effects of a synbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of s. BioSci Microflora 25: 137-146.
50. Turnbaugh PJ & Gordon JI (2009) The core gut microbiome, energy balance and obesity. J Physiol 587: 4153-4158.
51. Umeki M, Oue K, Mochizuki S, Shirai Y & Sakai K (2004) Effect of Lactobacillus rhamnosus KY-3 and cellobiose as synbiotics on lipid metabolism in rats. J Nutr Sci Vitaminol 50: 330-334.
52. Umeki M, Oue K, Mori M, Mochizuki S & Sakai K (2005) Fluorescent in situ hybridization analysis of cecal microflora in rats simultaneously administrated Lactobacillus rhamnosus KY-3 and cellobiose. Food Sci Technol Res 11: 168-170.
53. van Nuenen MHMC, Venema K, van der Woude JCJ & Kuipers EJ (2004) The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci 49: 485-491.
54. van Zanten GC, Knudsen A, Röytiö H, Forssten S, Lawther M, Blennow A, Lahtinen SJ, Jakobsen M, Svensson B & Jespersen L. (2012) The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon. PLoS One 7: e47212.
55. Venema K & van den Abbeele P (2013) Experimental models of the gut microbiome. Best Pract Res Clin Gastroenterol 27: 115-126.
56. Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME & Brigidi P (2010) Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 10: 4.
57. Walter J, Hertel C, Tannock GW, Lis CM, Munro K & Hammes WP (2001) Detection of Lactobacillus, Pediococcus, Leuconostoc and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67: 2578-2585.
58. Weiss G & Jespersen L (2010) Transcriptional analysis of genes associated with stress and adhesion in Lactobacillus acidophilus NCFM during the passage through an in vitro gastrointestinal tract model. J Mol Microbiol Biotechnol 18: 206-214.
59. Windey K, De Preter V & Verbeke K (2012) Relevance of protein fermentation to gut health. Mol Nutr Food Res 56: 184-196.
60. Wong JMW, de Souza R, Kendall CWC, Emam A & Jenkins DJA (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40: 235-243.
61. Worthley DL, Le Leu RK, Whitehall VL et al. (2009) A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic and synbiotics supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90: 578-586.
62. Yu Y, Lee C, Kim J & Hwang S (2005) Group-specific primer and probe sets to detect methanogenic communities using quantitative real-time polymerase chain reaction. Biotechnol Bioeng 89: 670-679.
63. + absorption and enzyme activity. Comp Biochem Physiol A Mol Integr Physiol 128: 335-347.